Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Shipley

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|July 31, 1982
A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid diseaseI A Williams, E M Baylis, M E Shipley
Annals of the Rheumatic Diseases|October 1, 1990
Specificity of rheumatoid factors in relation to the disease state in rheumatoid arthritisM G Jones, M E Shipley, J P Hearn, et al.
British Journal of Rheumatology|August 1, 1990
What do rheumatologists do? A pilot audit studyA N Bamji, P A Dieppe, D I Haslock, et al.
Rheumatology (Oxford, England)|October 7, 2008
Factors affecting self-efficacy and pain intensity in patients with chronic musculoskeletal pain seen in a specialist rheumatology pain clinicA Rahman, E Reed, M Underwood, et al.
British Journal of Pharmacology|January 1, 1980
Calcium ionophore A23187 induces release of chemokinetic and aggregating factors from polymorphonuclear leucocytesM A Bray, A W Ford-Hutchinson, M E Shipley, et al.
Annals of the Rheumatic Diseases|July 1, 1992
Ankylosing spondylitis and HLA-B27: restriction fragment length polymorphism and sequencing of an HLA-B27 allele from a patient with ankylosing spondylitisC M Higgins, T Lund, M E Shipley, et al.
Nature|July 17, 1980
Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesA W Ford-Hutchinson, M A Bray, M V Doig, et al.
British Journal of Rheumatology|June 1, 1988
Pulsed methylprednisolone in active early rheumatoid disease: a dose-ranging studyM E Shipley, P A Bacon, H Berry, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|July 31, 1982
A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid diseaseI A Williams, E M Baylis, M E Shipley
Annals of the Rheumatic Diseases|October 1, 1990
Specificity of rheumatoid factors in relation to the disease state in rheumatoid arthritisM G Jones, M E Shipley, J P Hearn, et al.
British Journal of Rheumatology|August 1, 1990
What do rheumatologists do? A pilot audit studyA N Bamji, P A Dieppe, D I Haslock, et al.
Rheumatology (Oxford, England)|October 7, 2008
Factors affecting self-efficacy and pain intensity in patients with chronic musculoskeletal pain seen in a specialist rheumatology pain clinicA Rahman, E Reed, M Underwood, et al.
British Journal of Pharmacology|January 1, 1980
Calcium ionophore A23187 induces release of chemokinetic and aggregating factors from polymorphonuclear leucocytesM A Bray, A W Ford-Hutchinson, M E Shipley, et al.
Annals of the Rheumatic Diseases|July 1, 1992
Ankylosing spondylitis and HLA-B27: restriction fragment length polymorphism and sequencing of an HLA-B27 allele from a patient with ankylosing spondylitisC M Higgins, T Lund, M E Shipley, et al.
Nature|July 17, 1980
Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesA W Ford-Hutchinson, M A Bray, M V Doig, et al.
British Journal of Rheumatology|June 1, 1988
Pulsed methylprednisolone in active early rheumatoid disease: a dose-ranging studyM E Shipley, P A Bacon, H Berry, et al.
Pageof 1